Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Suicide | 4 | 2026 | 140 | 1.700 |
Why?
|
| Nanoparticles | 8 | 2025 | 460 | 1.540 |
Why?
|
| Drug Design | 2 | 2024 | 186 | 1.500 |
Why?
|
| Metal Nanoparticles | 5 | 2025 | 230 | 1.490 |
Why?
|
| Ferric Compounds | 3 | 2025 | 62 | 1.100 |
Why?
|
| Palladium | 3 | 2025 | 30 | 1.090 |
Why?
|
| Biocompatible Materials | 3 | 2025 | 108 | 0.990 |
Why?
|
| Graphite | 3 | 2025 | 64 | 0.960 |
Why?
|
| Alginates | 3 | 2024 | 20 | 0.960 |
Why?
|
| Contrast Media | 1 | 2025 | 103 | 0.860 |
Why?
|
| Carbon | 6 | 2025 | 128 | 0.860 |
Why?
|
| Zirconium | 1 | 2024 | 11 | 0.850 |
Why?
|
| Biological Availability | 1 | 2024 | 116 | 0.850 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 62 | 0.840 |
Why?
|
| Silicon Dioxide | 2 | 2022 | 39 | 0.820 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 245 | 0.820 |
Why?
|
| Nanofibers | 1 | 2023 | 17 | 0.810 |
Why?
|
| Sulfamethoxazole | 1 | 2023 | 1 | 0.790 |
Why?
|
| Quantum Dots | 4 | 2025 | 38 | 0.790 |
Why?
|
| Proteins | 2 | 2023 | 382 | 0.780 |
Why?
|
| Copper | 3 | 2024 | 134 | 0.760 |
Why?
|
| Biosensing Techniques | 3 | 2025 | 136 | 0.740 |
Why?
|
| Plastics | 1 | 2022 | 14 | 0.740 |
Why?
|
| Hot Temperature | 2 | 2022 | 141 | 0.740 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1019 | 0.710 |
Why?
|
| Biomass | 2 | 2020 | 68 | 0.710 |
Why?
|
| Charcoal | 1 | 2020 | 7 | 0.670 |
Why?
|
| Lignin | 4 | 2021 | 8 | 0.660 |
Why?
|
| Sewage | 1 | 2020 | 27 | 0.660 |
Why?
|
| Nanotechnology | 2 | 2024 | 176 | 0.600 |
Why?
|
| Porosity | 5 | 2025 | 43 | 0.580 |
Why?
|
| Corchorus | 1 | 2018 | 2 | 0.570 |
Why?
|
| Oxygen | 3 | 2024 | 218 | 0.570 |
Why?
|
| Acids | 1 | 2018 | 19 | 0.560 |
Why?
|
| Glucose | 2 | 2022 | 244 | 0.540 |
Why?
|
| Search Engine | 1 | 2017 | 7 | 0.540 |
Why?
|
| Curcumin | 1 | 2018 | 118 | 0.510 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 532 | 0.510 |
Why?
|
| DNA | 1 | 2019 | 592 | 0.480 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 458 | 0.480 |
Why?
|
| Colonic Neoplasms | 2 | 2022 | 223 | 0.480 |
Why?
|
| Internet | 1 | 2017 | 236 | 0.470 |
Why?
|
| Humans | 28 | 2026 | 43102 | 0.470 |
Why?
|
| Ferrocyanides | 1 | 2015 | 3 | 0.460 |
Why?
|
| Cell Survival | 6 | 2025 | 945 | 0.460 |
Why?
|
| Durapatite | 1 | 2015 | 18 | 0.460 |
Why?
|
| Taiwan | 5 | 2026 | 23 | 0.460 |
Why?
|
| Microspheres | 1 | 2015 | 49 | 0.450 |
Why?
|
| Divorce | 1 | 2014 | 7 | 0.450 |
Why?
|
| Drug Delivery Systems | 5 | 2024 | 277 | 0.450 |
Why?
|
| Fever | 1 | 2015 | 62 | 0.440 |
Why?
|
| Cellulose | 3 | 2023 | 24 | 0.440 |
Why?
|
| Hepatocytes | 1 | 2015 | 80 | 0.440 |
Why?
|
| Cisplatin | 1 | 2015 | 98 | 0.440 |
Why?
|
| Cultural Characteristics | 1 | 2014 | 128 | 0.430 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 89 | 0.420 |
Why?
|
| Drug Carriers | 1 | 2015 | 174 | 0.410 |
Why?
|
| Vaccines | 2 | 2026 | 65 | 0.410 |
Why?
|
| Catalysis | 6 | 2024 | 187 | 0.390 |
Why?
|
| Gold | 3 | 2025 | 156 | 0.380 |
Why?
|
| Galectin 3 | 1 | 2012 | 30 | 0.380 |
Why?
|
| Nanostructures | 2 | 2025 | 161 | 0.370 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 70 | 0.370 |
Why?
|
| Animals | 13 | 2025 | 16992 | 0.360 |
Why?
|
| Particle Size | 5 | 2024 | 272 | 0.350 |
Why?
|
| Iron | 2 | 2024 | 251 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 432 | 0.340 |
Why?
|
| Platinum | 3 | 2022 | 23 | 0.340 |
Why?
|
| Photolysis | 2 | 2024 | 25 | 0.330 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1723 | 0.330 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 196 | 0.330 |
Why?
|
| Mice | 8 | 2025 | 6644 | 0.320 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 2676 | 0.290 |
Why?
|
| Electrochemical Techniques | 2 | 2025 | 32 | 0.290 |
Why?
|
| Water Pollutants, Chemical | 2 | 2024 | 171 | 0.280 |
Why?
|
| Electrons | 2 | 2025 | 76 | 0.270 |
Why?
|
| Surface Properties | 3 | 2024 | 160 | 0.270 |
Why?
|
| Zeolites | 2 | 2017 | 9 | 0.250 |
Why?
|
| Fluorescent Dyes | 2 | 2025 | 182 | 0.250 |
Why?
|
| Solvents | 2 | 2024 | 113 | 0.250 |
Why?
|
| Coloring Agents | 2 | 2023 | 55 | 0.240 |
Why?
|
| Polymers | 3 | 2022 | 155 | 0.240 |
Why?
|
| Famous Persons | 1 | 2026 | 5 | 0.240 |
Why?
|
| Bioelectric Energy Sources | 1 | 2025 | 2 | 0.240 |
Why?
|
| Mass Media | 1 | 2026 | 39 | 0.240 |
Why?
|
| Laccase | 1 | 2025 | 8 | 0.240 |
Why?
|
| Imidazoles | 2 | 2017 | 142 | 0.240 |
Why?
|
| Mice, Nude | 2 | 2025 | 408 | 0.240 |
Why?
|
| Nickel | 1 | 2025 | 23 | 0.240 |
Why?
|
| Aniline Compounds | 1 | 2025 | 28 | 0.230 |
Why?
|
| Hexuronic Acids | 2 | 2015 | 8 | 0.230 |
Why?
|
| Glucuronic Acid | 2 | 2015 | 8 | 0.230 |
Why?
|
| Osteoarthritis | 1 | 2025 | 25 | 0.230 |
Why?
|
| Organosilicon Compounds | 1 | 2025 | 4 | 0.230 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2025 | 40 | 0.230 |
Why?
|
| Hep G2 Cells | 2 | 2015 | 63 | 0.230 |
Why?
|
| Helicobacter pylori | 1 | 2025 | 118 | 0.220 |
Why?
|
| Tomography, X-Ray | 1 | 2024 | 1 | 0.220 |
Why?
|
| Hafnium | 1 | 2024 | 2 | 0.220 |
Why?
|
| Nanocomposites | 2 | 2022 | 22 | 0.220 |
Why?
|
| Photochemotherapy | 1 | 2024 | 43 | 0.210 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 16 | 0.210 |
Why?
|
| Suicide, Attempted | 1 | 2026 | 108 | 0.210 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2026 | 203 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2024 | 58 | 0.210 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 56 | 0.210 |
Why?
|
| Hordeum | 1 | 2024 | 15 | 0.210 |
Why?
|
| Temperature | 4 | 2020 | 313 | 0.200 |
Why?
|
| Emulsions | 1 | 2023 | 36 | 0.200 |
Why?
|
| Phenols | 3 | 2025 | 107 | 0.200 |
Why?
|
| Hepatitis B | 1 | 2023 | 41 | 0.200 |
Why?
|
| Polyesters | 1 | 2023 | 28 | 0.200 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 94 | 0.200 |
Why?
|
| Congo Red | 1 | 2023 | 4 | 0.200 |
Why?
|
| Nitrogen Compounds | 1 | 2023 | 5 | 0.200 |
Why?
|
| Peroxides | 1 | 2023 | 19 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 112 | 0.190 |
Why?
|
| Crohn Disease | 1 | 2023 | 71 | 0.190 |
Why?
|
| Silver | 1 | 2023 | 61 | 0.190 |
Why?
|
| Hyperthermia, Induced | 1 | 2023 | 28 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2023 | 94 | 0.190 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 60 | 0.190 |
Why?
|
| Ions | 2 | 2022 | 71 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 104 | 0.180 |
Why?
|
| Colorimetry | 1 | 2022 | 53 | 0.180 |
Why?
|
| Female | 9 | 2026 | 24698 | 0.180 |
Why?
|
| Pyrenes | 1 | 2022 | 26 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 306 | 0.180 |
Why?
|
| Pyrogallol | 1 | 2021 | 2 | 0.180 |
Why?
|
| Acetophenones | 1 | 2021 | 10 | 0.180 |
Why?
|
| Ligands | 1 | 2023 | 388 | 0.180 |
Why?
|
| Unemployment | 1 | 2022 | 29 | 0.180 |
Why?
|
| Poaceae | 1 | 2021 | 14 | 0.180 |
Why?
|
| Carcinoma | 1 | 2023 | 108 | 0.180 |
Why?
|
| Microwaves | 1 | 2021 | 29 | 0.180 |
Why?
|
| Molecular Structure | 1 | 2023 | 570 | 0.170 |
Why?
|
| Water Purification | 1 | 2021 | 32 | 0.170 |
Why?
|
| Ketamine | 1 | 2020 | 13 | 0.170 |
Why?
|
| Ecosystem | 1 | 2022 | 175 | 0.170 |
Why?
|
| Criminals | 1 | 2020 | 18 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2023 | 460 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2020 | 876 | 0.160 |
Why?
|
| Electrodes | 3 | 2025 | 59 | 0.160 |
Why?
|
| Research | 1 | 2022 | 181 | 0.160 |
Why?
|
| Levulinic Acids | 1 | 2019 | 2 | 0.160 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2022 | 83 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.160 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 457 | 0.160 |
Why?
|
| Chromium | 1 | 2019 | 28 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 495 | 0.150 |
Why?
|
| Doxorubicin | 3 | 2025 | 97 | 0.140 |
Why?
|
| Metals | 1 | 2019 | 114 | 0.140 |
Why?
|
| Caco-2 Cells | 2 | 2022 | 64 | 0.140 |
Why?
|
| Acetylation | 1 | 2018 | 107 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2018 | 986 | 0.140 |
Why?
|
| Ionic Liquids | 1 | 2018 | 20 | 0.140 |
Why?
|
| Male | 7 | 2026 | 23409 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 61 | 0.130 |
Why?
|
| RNA | 1 | 2019 | 266 | 0.130 |
Why?
|
| Smad4 Protein | 1 | 2017 | 8 | 0.130 |
Why?
|
| Dendrimers | 1 | 2016 | 15 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 41 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 347 | 0.130 |
Why?
|
| Catalase | 1 | 2017 | 110 | 0.130 |
Why?
|
| Attitude | 1 | 2017 | 108 | 0.120 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 57 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 220 | 0.120 |
Why?
|
| Polyethylene Glycols | 3 | 2023 | 108 | 0.120 |
Why?
|
| Language | 1 | 2017 | 185 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 508 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 667 | 0.120 |
Why?
|
| Galactosamine | 1 | 2015 | 4 | 0.120 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 9 | 0.120 |
Why?
|
| Thermogravimetry | 1 | 2015 | 7 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 358 | 0.120 |
Why?
|
| Urinary Bladder | 1 | 2015 | 30 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 216 | 0.110 |
Why?
|
| Magnetics | 1 | 2015 | 43 | 0.110 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 66 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2015 | 29 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 159 | 0.110 |
Why?
|
| Endocytosis | 1 | 2015 | 118 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 287 | 0.110 |
Why?
|
| Powders | 2 | 2024 | 20 | 0.100 |
Why?
|
| Freeze Drying | 2 | 2024 | 29 | 0.100 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 89 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2013 | 12 | 0.100 |
Why?
|
| Hydrogels | 2 | 2024 | 59 | 0.100 |
Why?
|
| Gastrointestinal Agents | 2 | 2023 | 6 | 0.100 |
Why?
|
| Remission Induction | 2 | 2023 | 19 | 0.100 |
Why?
|
| Arteriosclerosis | 1 | 2013 | 43 | 0.100 |
Why?
|
| raf Kinases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2013 | 64 | 0.100 |
Why?
|
| Cell Movement | 2 | 2017 | 655 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 587 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.090 |
Why?
|
| Nitrogen | 2 | 2024 | 84 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 129 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1596 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2013 | 87 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 72 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 54 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 74 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2012 | 158 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 56 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 189 | 0.090 |
Why?
|
| Child | 3 | 2026 | 3443 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2023 | 190 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2013 | 269 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 1028 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2544 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 228 | 0.080 |
Why?
|
| Incidence | 2 | 2026 | 1078 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 436 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 224 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2022 | 184 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2025 | 1455 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2023 | 1604 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 968 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2026 | 6 | 0.060 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2025 | 27 | 0.060 |
Why?
|
| Limit of Detection | 1 | 2025 | 94 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2025 | 50 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2025 | 86 | 0.060 |
Why?
|
| Neoplasms | 1 | 2016 | 1377 | 0.060 |
Why?
|
| Middle Aged | 3 | 2026 | 12222 | 0.060 |
Why?
|
| Dogs | 1 | 2025 | 204 | 0.060 |
Why?
|
| Molybdenum | 1 | 2024 | 22 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2024 | 64 | 0.060 |
Why?
|
| Fibrosis | 1 | 2025 | 169 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2024 | 48 | 0.050 |
Why?
|
| Adult | 3 | 2026 | 13872 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2026 | 341 | 0.050 |
Why?
|
| Tungsten | 1 | 2024 | 8 | 0.050 |
Why?
|
| Bismuth | 1 | 2024 | 6 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2024 | 23 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2024 | 72 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 92 | 0.050 |
Why?
|
| Disulfides | 1 | 2024 | 95 | 0.050 |
Why?
|
| Aerosols | 1 | 2024 | 54 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 281 | 0.050 |
Why?
|
| Minerals | 1 | 2024 | 53 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 97 | 0.050 |
Why?
|
| Methylene Blue | 1 | 2023 | 7 | 0.050 |
Why?
|
| Cotton Fiber | 1 | 2023 | 5 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2023 | 47 | 0.050 |
Why?
|
| Recurrence | 1 | 2023 | 152 | 0.050 |
Why?
|
| Antigens | 1 | 2023 | 59 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2023 | 4 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2023 | 10 | 0.050 |
Why?
|
| Tetracycline | 1 | 2023 | 17 | 0.050 |
Why?
|
| Light | 1 | 2024 | 185 | 0.050 |
Why?
|
| Aged | 2 | 2026 | 8214 | 0.050 |
Why?
|
| Papillomavirus Vaccines | 1 | 2026 | 174 | 0.050 |
Why?
|
| Nitrophenols | 1 | 2022 | 5 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2026 | 1285 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 53 | 0.050 |
Why?
|
| Peroxidase | 1 | 2022 | 57 | 0.050 |
Why?
|
| Sulfur | 1 | 2022 | 22 | 0.050 |
Why?
|
| Adolescent | 2 | 2026 | 6081 | 0.050 |
Why?
|
| Aluminum Oxide | 1 | 2021 | 11 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2023 | 259 | 0.050 |
Why?
|
| Distillation | 1 | 2021 | 3 | 0.050 |
Why?
|
| Titanium | 1 | 2022 | 48 | 0.040 |
Why?
|
| Pyrroles | 1 | 2021 | 72 | 0.040 |
Why?
|
| Alcohols | 1 | 2020 | 14 | 0.040 |
Why?
|
| Electrochemistry | 1 | 2020 | 38 | 0.040 |
Why?
|
| Micelles | 1 | 2020 | 36 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 355 | 0.040 |
Why?
|
| Water | 1 | 2023 | 316 | 0.040 |
Why?
|
| Biofuels | 1 | 2020 | 15 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 155 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 83 | 0.040 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 44 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 2853 | 0.040 |
Why?
|
| Phototherapy | 1 | 2016 | 25 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 62 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 74 | 0.030 |
Why?
|
| Surface-Active Agents | 1 | 2016 | 46 | 0.030 |
Why?
|
| Alloys | 1 | 2016 | 6 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2016 | 19 | 0.030 |
Why?
|
| Amination | 1 | 2016 | 6 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 416 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 51 | 0.030 |
Why?
|
| Aldehydes | 1 | 2016 | 70 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 506 | 0.030 |
Why?
|
| Young Adult | 1 | 2026 | 5080 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 695 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1124 | 0.030 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 8 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 38 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2013 | 68 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1621 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 212 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 701 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1568 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1151 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.020 |
Why?
|